SEC Filing | IDEX Corporation

View:

IEX-2014.01.29-8K

▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8‑K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report: January 29, 2014

(Date of earliest event reported)

IDEX CORPORATION
(Exact name of registrant as specified in its charter)



Delaware	1-10235	36-3555336
(State of	(Commission File Number)	(IRS Employer
Incorporation)		Identification No.)

1925 W. Field Court
Lake Forest, Illinois 60045
(Address of principal executive offices, including zip code)

(847) 498-7070
(Registrant’s telephone number, including area code)

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 – Results of Operations and Financial Condition.

On January 29, 2014, IDEX Corporation (the “Company”) issued a press release announcing financial results for the period ended December 31, 2013.

A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Current Report furnished pursuant to Item 2.02 shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. This information shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended.

Item 9.01 – Financial Statements and Exhibits.


(d)	Exhibits


99.1	Press release dated January 29, 2014 announcing IDEX Corporation’s quarterly operating results

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

IDEX CORPORATION


By:	/s/ Heath A. Mitts

Heath A. Mitts

Vice President and Chief Financial Officer

January 30, 2014

Exhibit Index



Exhibit Number		Description


99.1	Press release dated January 29, 2014 announcing IDEX Corporation’s quarterly operating results

IEX-2014.01.29-EX99.1

EXHIBIT 99.1

IDEX REPORTS 15 PERCENT EPS GROWTH AND 28 PERCENT FREE CASH FLOW GROWTH IN 2013; Q4 EPS OF 82 CENTS DRIVEN BY 20 PERCENT OPERATING MARGIN

LAKE FOREST, IL, JANUARY 29 - IDEX Corporation (NYSE: IEX) today announced its financial results for the three- and twelve- month periods ended December 31, 2013.

Full Year 2013 Highlights


•	Orders of $2.1 billion increased 7 percent compared to the prior year (+5 percent organic and +2 percent acquisition).


•	Sales of $2.0 billion increased 4 percent compared to the prior year (+2 percent organic and +2 percent acquisition).


•	Gross margin of 43.1 percent was up 200 basis points from the prior year.


•	Operating margin of 19.5 percent was up 110 basis points from the adjusted prior year.


•	Net income of $255 million represents an increase of 14 percent compared to the adjusted prior year net income of $224 million.


•	EPS of $3.09 was 41 cents, or 15 percent, higher than the adjusted prior year EPS of $2.68.


•	EBITDA of $475 million, which represents an 8 percent increase from the adjusted prior year, was 23 percent of sales and covered interest expense by over 11 times.


•	Free cash flow of $379 million, which represents a 28 percent increase from the prior year, was 148 percent of net income.


•	The Company completed the repurchase of 2.9 million shares of common stock for $166 million in 2013.

Fourth Quarter 2013

Orders in the quarter of $519 million were up 8 percent from the prior year period. Sales in the quarter totaled $521 million, 6 percent higher than the prior year period. For the quarter, on an organic basis, orders were 7 percent higher and sales were 5 percent higher than the prior year period.

Fourth quarter 2013 operating income was $104 million, up 14% from the adjusted prior year period. This resulted in an operating margin of 20 percent, up 150 basis points from the adjusted prior year operating margin, primarily due to volume leverage and productivity. Operating income includes $6 million of charges associated with cost-out actions across our three segments partially offset by a $4 million gain on the settlement of the contingent consideration agreement related to the Matcon business acquired in July 2012.

Fourth quarter net income was $68 million, an increase of 18 percent from the adjusted prior year. Fourth quarter earnings per share were 82 cents, an increase of 13 cents, or 19 percent, from the adjusted prior year.

Free cash flow of $95 million was a 20 percent increase from the prior year and 140 percent of net income.

“IDEX finished 2013 with a strong fourth quarter, culminating in a record year. Our flexible operating model allowed us to improve our cost structure and reinvest in organic growth. For the full year 2013, we delivered 7 percent order growth, expanded operating margins to 19.5 percent, generated record free cash flow of $379 million, and achieved 15 percent EPS growth.

The fourth quarter saw markets continue to stabilize, and sustained order growth in the second half of 2013 provides solid momentum heading into 2014. In the fourth quarter, we took targeted cost-out actions across our three segments to further optimize our operating footprint. Based on these actions and improved performance throughout 2013, we now expect the Company’s operating margins for 2014 to exceed 20 percent. I am proud of our 2013 accomplishments and I am confident in IDEX’s ability to capitalize on long-term growth opportunities.

Fueled by free cash flow conversion of 148 percent in 2013, we returned a record $240 million to shareholders via dividends and share repurchases. Our balance sheet and ability to generate cash are stronger than ever.

As we enter 2014, we will continue to rigorously allocate our capital and people where we can create advantage and value. Our strategy of fully funding organic growth is unchanged, and we are committed to further increasing shareholder value through strategic acquisitions, shareholder dividends and share repurchases.

We expect global end market demand to remain uneven. Regardless, with our focused efforts, we anticipate 3 to 5 percent organic revenue growth in 2014 and EPS of $3.33 to $3.43, up 8 to 11 percent compared to 2013. We expect first quarter 2014 EPS to be in the range of 83 to 85 cents, up 12 to 15 percent.”

Andrew K. Silvernail

Chairman and Chief Executive Officer

Fourth Quarter 2013 Business Highlights (Operating margin excludes non-cash impairment and restructuring charges in 2012)

Fluid & Metering Technologies


•	Sales in the fourth quarter of $222 million reflected a 5 percent increase compared to the fourth quarter of 2012 (+4 percent organic and +1 percent foreign currency translation).


•	Operating margin of 24.9 percent represented a 390 basis point improvement compared with the fourth quarter of 2012 primarily due to higher volume and productivity initiatives partially offset by $2 million of charges associated with cost-out actions taken during the quarter.

Health & Science Technologies


•	Sales in the fourth quarter of $182 million reflected a 4 percent increase compared to the fourth quarter of 2012 (+2 percent organic, +3 percent acquisitions and -1 percent foreign currency translation).


•	Operating margin of 18.2 percent represented a 20 basis point decrease compared with the fourth quarter of 2012 primarily due to $3 million of charges associated with cost-out actions taken during the quarter, partially offset by higher volume and productivity initiatives.

Fire & Safety/Diversified Products


•	Sales in the fourth quarter of $118 million reflected a 9 percent increase compared to the fourth quarter of 2012 (+8 percent organic and +1 percent foreign currency translation).


•	Operating margin of 24.3 percent represented a 10 basis point increase compared with the fourth quarter of 2012 primarily due to higher volume and productivity initiatives partially offset by $1 million of charges associated with cost-out actions taken during the quarter.

For the fourth quarter of 2013, Fluid & Metering Technologies contributed 42 percent of sales and 47 percent of operating income; Health & Science Technologies accounted for 35 percent of sales and 28 percent of operating income; and Fire & Safety/Diversified Products represented 23 percent of sales and 25 percent of operating income.

EBITDA and Free Cash Flow

EBITDA means earnings before interest, income taxes, depreciation and amortization, while free cash flow means cash flow from operating activities less capital expenditures plus the excess tax benefit from stock-based compensation. Management uses these non-GAAP financial measures as internal operating metrics and for enterprise valuation purposes. Management believes these measures are useful as analytical indicators of leverage capacity and debt servicing ability, and uses them to measure financial performance as well as for planning purposes. However, they should not be considered as alternatives to net income, cash flow

from operating activities or any other items calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The definitions of EBITDA and free cash flow used here may differ from those used by other companies.

EBITDA and Free Cash Flow Bridge (dollars in millions)

Conference Call to be Broadcast over the Internet

IDEX will broadcast its fourth quarter earnings conference call over the Internet on Thursday, January 30, 2014 at 9:30 a.m. CT. Chairman and Chief Executive Officer Andy Silvernail and Vice President and Chief Financial Officer Heath Mitts will discuss the Company’s recent financial performance and respond to questions from the financial analyst community. IDEX invites interested investors to listen to the call and view the accompanying slide presentation, which will be carried live on its website at www.idexcorp.com. Those who wish to participate should log on several minutes before the discussion begins. After clicking on the presentation icon, investors should follow the instructions to ensure their systems are set up to hear the event and view the presentation slides, or download the correct applications at no charge. Investors will also be able to hear a replay of the call by dialing 855.859.2056 (or 404.537.3406 for international participants) using the ID # 30410743.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. These statements may relate to, among other things, capital expenditures, cost reductions, cash flow,

and operating improvements and are indicated by words or phrases such as “anticipate,” “estimate,” “plans,” “expects,” “projects,” “should,” “will,” “management believes,” “the company believes,” “the company intends,” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include, but are not limited to, the following: economic and political consequences resulting from terrorist attacks and wars; levels of industrial activity and economic conditions in the U.S. and other countries around the world; pricing pressures and other competitive factors, and levels of capital spending in certain industries - all of which could have a material impact on order rates and IDEX’s results, particularly in light of the low levels of order backlogs it typically maintains; its ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which the company operates; interest rates; capacity utilization and the effect this has on costs; labor markets; market conditions and material costs; and developments with respect to contingencies, such as litigation and environmental matters. The forward-looking statements included here are only made as of the date of this news release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.

About IDEX

IDEX Corporation is an applied solutions company specializing in fluid and metering technologies, health and science technologies, and fire, safety and other diversified products built to its customers’ exacting specifications. Its products are sold in niche markets to a wide range of industries throughout the world. IDEX shares are traded on the New York Stock Exchange and Chicago Stock Exchange under the symbol “IEX”.

For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com.

(Tables follow)



IDEX CORPORATION
Condensed Statements of Consolidated Operations
(in thousands except per share amounts)
(unaudited)


	Three Months Ended					Twelve Months Ended
	December 31,					December 31,
	2013		2012			2013		2012

Net sales	$	520,620	$	490,838		$	2,024,130	$	1,954,258
Cost of sales	293,611		287,980			1,150,766		1,150,558
Gross profit	227,009		202,858			873,364		803,700
Selling, general and administrative expenses	123,136		112,059			477,851		444,490
Impairment	—		198,519			—		198,519
Restructuring expenses	—		17,869			—		32,473
Operating income (loss)	103,873		(125,589		)	395,513		128,218
Other (income) expense - net	696		(217		)	178		(236		)
Interest expense	10,482		10,516			42,206		42,250
Income (loss) before income taxes	92,695		(135,888		)	353,129		86,204
Provision (benefit) for income taxes	25,140		(16,869		)	97,914		48,574
Net income (loss)	$	67,555	$	(119,019	)	$	255,215	$	37,630


Earnings per Common Share:
Basic earnings (loss) per common share ^(a)	$	0.83	$	(1.45	)	$	3.11	$	0.45
Diluted earnings (loss) per common share ^(a)	$	0.82	$	(1.45	)	$	3.09	$	0.45


Share Data:

Basic weighted average common shares outstanding	$	80,782	$	82,296		$	81,517	$	82,689

Diluted weighted average common shares outstanding	$	81,854	$	82,296		$	82,489	$	83,641



Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
	December 31,		December 31,
	2013		2012

Assets
Current assets
Cash and cash equivalents	$	439,629	$	318,864
Receivables - net	253,226		256,095
Inventories	230,967		234,950
Other current assets	67,131		71,956
Total current assets	990,953		881,865
Property, plant and equipment - net	213,488		219,161
Goodwill and intangible assets	1,660,683		1,663,099
Other noncurrent assets	22,453		21,265
Total assets	$	2,887,577	$	2,785,390

Liabilities and shareholders' equity
Current liabilities
Trade accounts payable	$	133,312	$	117,341
Accrued expenses	150,751		150,176
Short-term borrowings	1,871		7,335
Dividends payable	18,675		16,575
Total current liabilities	304,609		291,427
Long-term borrowings	772,005		779,241
Other noncurrent liabilities	237,974		249,724
Total liabilities	1,314,588		1,320,392
Shareholders' equity	1,572,989		1,464,998
Total liabilities and shareholders' equity	$	2,887,577	$	2,785,390



IDEX CORPORATION
Company and Business Group Financial Information
(dollars in thousands)
(unaudited)


		Three Months Ended						Twelve Months Ended
		December 31, ^(b)						December 31, ^(b)
		2013			2012 ^(c)			2013			2012 ^(c)

	Fluid & Metering Technologies
	Net sales	$	222,234		$	211,855		$	871,814		$	833,288
	Operating income ^(c)	55,326			44,455			211,256			180,630
	Operating margin	24.9		%	21.0		%	24.2		%	21.7		%
	Depreciation and amortization	$	6,680		$	7,445		$	27,633		$	29,637
	Capital expenditures	3,455			3,784			11,581			13,535

	Health & Science Technologies
	Net sales	$	182,287		$	174,661		$	714,650		$	695,235
	Operating income ^(c)	33,143			32,214			136,707			122,708
	Operating margin	18.2		%	18.4		%	19.1		%	17.6		%
	Depreciation and amortization	$	10,959		$	10,687		$	43,496		$	39,981
	Capital expenditures	2,503			2,704			12,280			13,140

	Fire & Safety/Diversified Products
	Net sales	$	118,223		$	108,880		$	445,049		$	437,053
	Operating income ^(c)	28,703			26,296			102,730			104,461
	Operating margin	24.3		%	24.2		%	23.1		%	23.9		%
	Depreciation and amortization	$	1,677		$	1,881		$	6,852		$	7,107
	Capital expenditures	2,043			1,471			5,040			6,654

	Company
	Net sales	$	520,620		$	490,838		$	2,024,130		$	1,954,258
	Operating income ^(c)	103,873			90,799			395,513			359,210
	Operating margin	20.0		%	18.5		%	19.5		%	18.4		%
	Depreciation and amortization ^(d)	$	19,639		$	20,374		$	79,334		$	78,312
	Capital expenditures	8,396			8,254			31,536			35,520


(a)	Calculated by applying the two-class method of allocating earnings to common stock and participating securities as required by ASC 260, Earnings Per Share.

(b)	Three and twelve month data includes acquisitions of FTL (March 2013), Matcon (July 2012) and ERC (April 2012) in the Health & Science Technologies segment from the date of acquisition.

(c)	Group operating income excludes unallocated corporate operating expenses while both Group and Company operating income excludes the impairment charge (for the Fluid & Metering Technologies and Health & Science Technologies segments) and restructuring related charges for 2012.

(d)	Depreciation and amortization excludes amortization of debt issuance expenses.